Image Description (Pregabalin Capsule 100mg 90s Bottle Label)
Pregabalin Capsule
Product Images NDC 62135-445
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 62135-445). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image Description (Pregabalin Capsule 150mg 90s Bottle Label)
Image Description (Pregabalin Capsule 50mg 90s Bottle Label)
Image Description (Pregabalin Capsule 75mg 90s Bottle Label)
Image Description (Pregabalin Capsule Figure 1)
Image Description (Pregabalin Capsule Figure 10)
Image Description (Pregabalin Capsule Figure 11)
Image Description (Pregabalin Capsule Figure 12)
This text provides a formula to calculate the creatinine clearance (CLCr) in patients based on their age and weight. The formula is given as [140 - age (years)] x weight (kg), and the result obtained can be multiplied by 0.85 for female patients. CLCr is a measure of renal function and is commonly used in medicine to assess kidney function in patients.*
Image Description (Pregabalin Capsule Figure 2)
This is a report of the percentage of patients who experienced improvement in pain from a baseline when using Pregabalin at a dosage of 100mg twice a day. There is also a chart showing the percentage improvement in pain over time, but the details are not entirely clear.*
Image Description (Pregabalin Capsule Figure 3)
This text is a table chart with medication dosages and percentages of pain improvement. It is not possible to create a useful description with this information alone.*
Image Description (Pregabalin Capsule Figure 4)
The text describes a study on the improvement of patients' parents. The effectiveness of Pregabalin in reducing pain is evaluated by administering different dosages of the drug (200 mg and 100 mg) and a placebo. The results are shown in a graph indicating the percentage of pain improvement from the baseline.*
Image Description (Pregabalin Capsule Figure 5)
Image Description (Pregabalin Capsule Figure 6)
Image Description (Pregabalin Capsule Figure 7)
Image Description (Pregabalin Capsule Figure 8)
Image Description (Pregabalin Capsule Figure 9)
This appears to be a chart displaying estimated percentages of subjects without a specific abbreviation or term represented by "LTR". The chart includes various percentages ranging from 0% to 100%, with corresponding values shown on the right-hand side of the chart. However, without additional context or information, the meaning or relevance of these percentages is not clear.*
Image Description (Pregabalin Capsule Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
